Literature DB >> 2548638

A comparison of bradykinin, angiotensin II and muscarinic stimulation of cultured bovine adrenal chromaffin cells.

A J O'Sullivan1, R D Burgoyne.   

Abstract

Bradykinin, angiotensin II and a muscarinic agonist, acetyl-B-methacholine (methacholine) were all found to elicit catecholamine release from cultured bovine adrenal chromaffin cells. Bradykinin was the most potent of these secretagogues and methacholine the weakest, with angiotensin II intermediate in efficacy. All three secretagogues were much less effective than nicotinic stimulation. The three secretagogues all produced a rise in cytoplasmic free calcium concentration ([Ca2+]i), measured with the fluorescent indicator fura2, which was partially independent of external calcium. In the case of bradykinin the full rise in ([Ca2+]i) may involve a component of calcium entry in addition to release of calcium from an internal store. Secretion was also found to be partially independent of external calcium. The different efficacies of the three secretagogues in eliciting secretion were correlated with the rise in ([Ca2+]i) produced. The differing efficacies of the three secretagogues may be due to the extent of release of calcium from an intracellular store which itself is less effective in eliciting secretion than a rise in [Ca2+]i following calcium entry due to nicotine. Bradykinin also stimulates calcium entry, and this may increase the efficacy of the initial rise in [Ca2+]i. Treatment with pertussis toxin resulted in an enhancement of secretion in response to all of the secretagogues.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548638     DOI: 10.1007/BF01116001

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  19 in total

1.  Angiotensin II causes calcium entry into bovine adrenal chromaffin cells via pathway(s) activated by depletion of intracellular calcium stores.

Authors:  David A Powis; Mariann Zerbes; Lynn M Herd; Peter R Dunkley
Journal:  Neurochem Res       Date:  2003-09       Impact factor: 3.996

2.  Ca(2+)-stores mobilization by diadenosine tetraphosphate, Ap4A, through a putative P2Y purinoceptor in adrenal chromaffin cells.

Authors:  E Castro; J Pintor; M T Miras-Portugal
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

3.  Agonist-dependent patterns of cytosolic Ca2+ changes in single bovine adrenal chromaffin cells: relationship to catecholamine release.

Authors:  K A Stauderman; M M Murawsky; R M Pruss
Journal:  Cell Regul       Date:  1990-08

Review 4.  Noncholinergic control of adrenal catecholamine secretion.

Authors:  B G Livett; P D Marley
Journal:  J Anat       Date:  1993-10       Impact factor: 2.610

5.  Single-cell fura-2 microfluorometry reveals different purinoceptor subtypes coupled to Ca2+ influx and intracellular Ca2+ release in bovine adrenal chromaffin and endothelial cells.

Authors:  E Castro; A R Tomé; M T Miras-Portugal; L M Rosário
Journal:  Pflugers Arch       Date:  1994-04       Impact factor: 3.657

6.  Exocytosis in bovine chromaffin cells: studies with patch-clamp capacitance and FM1-43 fluorescence.

Authors:  Gordan Kilic
Journal:  Biophys J       Date:  2002-08       Impact factor: 4.033

7.  Small-conductance Ca(2+)-activated K+ channels in bovine chromaffin cells.

Authors:  A R Artalejo; A G García; E Neher
Journal:  Pflugers Arch       Date:  1993-04       Impact factor: 3.657

Review 8.  Exocytosis in adrenal chromaffin cells.

Authors:  R D Burgoyne; A Morgan; I Robinson; N Pender; T R Cheek
Journal:  J Anat       Date:  1993-10       Impact factor: 2.610

9.  GABAB receptors modulate catecholamine secretion in chromaffin cells by a mechanism involving cyclic AMP formation.

Authors:  M J Oset-Gasque; M Parramón; M P González
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

10.  Role of protein kinase C in the regulation of histamine and bradykinin stimulated inositol polyphosphate turnover in adrenal chromaffin cells.

Authors:  M R Boarder; R A Challiss
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.